Nalaganje...
Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38
BACKGROUND: Body mass index (BMI) has been associated with breast cancer (BC) outcomes. However, few studies used clinical trial settings where treatments and outcomes are consistently evaluated and documented. There are also limited data assessing how patient/disease characteristics and treatment m...
Shranjeno v:
| izdano v: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4713289/ https://ncbi.nlm.nih.gov/pubmed/26545405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-15-0334-T |
| Oznake: |
Označite
Brez oznak, prvi označite!
|